Clinical Trial 55837

Huntington Beach, CA 92647


A Phase 3, randomized, double-blind, placebo-controlled, parallel-group, 3-arm, multinational, multicenter study to evaluate the efficacy and safety of amlitelimab monotherapy by subcutaneous injection in participants aged 18 years and older with moderate-to-severe atopic dermatitis.

Qualified Participants Must:

• 18 years or older
• Clinically diagnosed with Atopic Dermititis
• Moderate to Severe Eczema

Qualified Participants May Receive:

Possible eczema Relief

No Cost Medicine

Preliminary Assessment at No Cost

Compensation for time and travel - up to $3,000

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.